pimagedine has been researched along with Conus Medullaris Syndrome in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, WB | 1 |
| Lv, G | 1 |
| Wang, YF | 1 |
| Lu, XH | 1 |
| Huang, T | 1 |
| Zhu, Y | 1 |
| Jia, LS | 1 |
1 other study available for pimagedine and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Combination of dexamethasone and aminoguanidine reduces secondary damage in compression spinal cord injury.
Topics: Animals; bcl-2-Associated X Protein; Blotting, Western; Body Fluids; Dexamethasone; Drug Therapy, Co | 2009 |